Healthcare · Biotechnology

Is Lakewood-Amedex Biotherapeutics, Inc. (LABT) Stock Halal?

Shariah Compliance Across 5 Standards — Live

NON-COMPLIANTMarket cap $4.6M
Screened 2026-07-11Halal Terminal screening engineSource: latest public financial filings

Shariah Compliance Verdict — 5 Standards

AAOIFI (Shari'ah Standard 21)market-cap basis

impure income 100.0% > 5%

NON-COMPLIANT

Dow Jones Islamic Marketmarket-cap basis

impure income 100.0% > 5%

NON-COMPLIANT

FTSE Shariah (Yasaar)total-assets basis

debt/assets 66.9% > 33%; impure income 100.0% > 5%

NON-COMPLIANT

MSCI Islamictotal-assets basis

debt/assets 66.9% > 33%; impure income 100.0% > 5%

NON-COMPLIANT

S&P Shariahmarket-cap basis

impure income 100.0% > 5%

NON-COMPLIANT

Live verdicts from the Halal Terminal screening engine, recomputed against the issuer's latest filings.

Plain-English Summary

Fails AAOIFI, DJIM, FTSE, MSCI, S&P on interest/revenue 100.0% > AAOIFI 5%, DJIM 5%, FTSE 5%, MSCI 5%, S&P 5%; debt/assets 66.9% > FTSE 33%, MSCI 33%.

Business Activity Screen

Business activity is compliant.

Financial Ratios

Interest-bearing debt / market cap

AAOIFI ≤30% · DJIM/S&P <33% (trailing-avg MC)

2.9%

Cash & interest-bearing / market cap

AAOIFI ≤30% of market cap

0.3%

Debt / total assets

FTSE/MSCI <33.33% of total assets

66.9%

Cash & interest-bearing / total assets

FTSE/MSCI <33.33% of total assets

6.0%

Interest income / revenue

≤5% across all methodologies

100.0%

Raw ratios from the latest filings — each methodology applies its own basis and thresholds (see the verdict box above for per-standard outcomes).

Balance-Sheet Trajectory (2 Quarters)

Quarter endDebt / assetsCash / assetsReceivables + cash / assets
2025-12-3133.3%49.1%49.1%
2026-03-3166.9%6.0%6.0%

A stock that has screened comfortably for eight straight quarters is a different story from one that crossed a threshold last quarter — trajectory shows which one this is.

Frequently Asked Questions

Is Lakewood-Amedex Biotherapeutics, Inc. (LABT) halal to invest in?

Lakewood-Amedex Biotherapeutics, Inc. currently screens as non-compliant on the Halal Terminal engine. The verdict is recomputed against the issuer's latest financial filings and all five major methodologies (AAOIFI, DJIM, FTSE, MSCI, S&P) — see the per-standard breakdown above. This is a data-driven application of published standards, not a fatwa.

Is LABT compliant under AAOIFI?

No — LABT currently fails AAOIFI screening: impure income 100.0% > 5%.

Do I need to purify dividends from LABT?

A purification rate could not be computed from the latest filings; consult the methodology page for how purification works.

Why do halal screening apps disagree about LABT?

Different services apply different ratio bases (market capitalization vs total assets), different revenue classifications, and different data vintages. This page shows both AAOIFI readings side by side and classifies revenue segments explicitly so the source of any disagreement is visible.

All Healthcare

Screen Your Full Portfolio

Halal Terminal screens stocks and ETFs across 5 Shariah standards simultaneously — with live ratios, segment-level business income, purification calculations, and Zakat reports.

Disclaimer: This page is for educational and informational purposes only and does not constitute financial or religious advice. Verdicts and figures come from the Halal Terminal screening engine, computed from the issuer's public financial filings and refreshed regularly (last screened 2026-07-11). This is a data-driven application of published Shariah standards — not a fatwa. Consult a qualified Islamic finance scholar or advisor for personalised guidance.